CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Oncotarget 2018 Sep 28;9(76):34193-34195. Epub 2018 Sep 28.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188130PMC
September 2018
5 Reads

Publication Analysis

Top Keywords

receptor her2-negative
4
factor receptor
4
epidermal growth
4
her2-negative metastatic
4
metastatic breast
4
finish line?
4
cancer finish
4
breast cancer
4
human epidermal
4
growth factor
4
receptor-positive human
4
inhibitors hormone
4
hormone receptor-positive
4
cdk4/6 inhibitors
4
cancer
1
receptor-positive
1
finish
1
line?
1
hormone
1
breast
1

Similar Publications